Skip to main content
Clinical Trials/NCT06327373
NCT06327373
Not yet recruiting
Phase 1

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

Duke University11 sites in 1 country10 target enrollmentJuly 1, 2026

Overview

Phase
Phase 1
Intervention
Room air
Conditions
Pulmonary Hypertension
Sponsor
Duke University
Enrollment
10
Locations
11
Primary Endpoint
Change daily hypoxemia burden
Status
Not yet recruiting
Last Updated
8 months ago

Overview

Brief Summary

The purpose of this study is to assess the feasibility of supplemental oxygen delivery during hemodialysis in people with pulmonary hypertension and intradialytic hypoxemia.

Registry
clinicaltrials.gov
Start Date
July 1, 2026
End Date
June 30, 2027
Last Updated
8 months ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults ≥18 years
  • Receiving Monday-Wednesday-Friday or Tuesday-Thursday-Saturday hemodialysis
  • Screened positive for pulmonary hypertension (defined by tricuspid regurgitant velocity \[TRV\] \>2.5 m/s on echocardiography) and intradialytic hypoxemia (defined by spending ≥1/3 treatment with O2 saturation \<90%) or hypoxemia for ≥10% of the treatment if associated with a desaturation event (≥4% decline in O2 saturation to \<88% for ≥10 seconds) during enrollment in the PH-ESKD study (Pro00108710).

Exclusion Criteria

  • Daily supplemental oxygen use
  • Inability to provide informed consent

Arms & Interventions

Room air

Participants will receive no supplemental oxygen.

Intervention: Room air

Supplemental oxygen (0.5 liters per minute)

Participants will receive supplemental oxygen by oxygen concentrator delivered by nasal cannula at 0.5 liters per minute.

Intervention: Oxygen

Supplemental oxygen (3 liters per minute)

Participants will receive supplemental oxygen by oxygen concentrator delivered by nasal cannula at 3 liters per minute.

Intervention: Oxygen

Outcomes

Primary Outcomes

Change daily hypoxemia burden

Time Frame: Weeks 1, 2, and 3

Minutes with oxygen saturation \<90% over a 24-hour period assessed by pulse oximetry

Secondary Outcomes

  • Change in six minute walk distance(Weeks 1 and 3)
  • Change in Montreal Cognitive Assessment (MoCA)(Weeks 1 and 3)

Study Sites (11)

Loading locations...

Similar Trials